Solasta Ventures
Home Approach Portfolio
News Team Hatchery Contact
HomeApproachPortfolio
Solasta Ventures
NewsTeamHatcheryContact
Orionis Biosciences Debuts with Major Pharmaceutical Collaboration to Tackle Industry’s Most Challenging Protein Targets
Nia JulianMarch 9, 2020
Facebook0 Twitter Pinterest0 0 Likes
Previous

Rallybio Completes $145 Million Series B Financing and Announces Plans to Advance Lead Product Candidate into the Clinic in 2H 2020

Nia JulianMay 19, 2020
Next

Akrevia Therapeutics Rebrands as Xilio Therapeutics and Announces $100.5 Million Series B Financing

Nia JulianMarch 3, 2020

© 2020 Solasta Ventures. All Rights Reserved.